| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine, Division of Pulmonary and Critical Care Medicine, State University of New York at Buffalo and Department of Veterans Affairs Western New York Healthcare System, Buffalo, NY.
Correspondence to: Sanjay Sethi, MD, Veterans Affairs Western New York Healthcare System (151), 3495 Bailey Ave, Buffalo, NY 14215; e-mail: sethi.sanjay{at}buffalo.va.gov
Infectious agents are a major cause of acute exacerbations of chronic bronchitis (AECB) and COPD. Several respiratory viruses are associated with 30% of exacerbations, with or without a superimposed bacterial infection. Atypical bacteria, mostly Chlamydia pneumoniae, have been implicated in < 10% of AECB. The role of bacterial pathogens when isolated from the respiratory tract during AECB has become better defined by application of several newer investigative techniques. Bacterial pathogens can be isolated in significant concentrations from distal airways in 50% of AECB. Specific immune responses to surface exposed antigens of the infecting pathogen have been shown to develop after an exacerbation. Emerging evidence from molecular epidemiology and measurement of airway inflammation further support the role of bacteria in AECB. When properly defined, 80% of AECB are likely to be infectious in origin.
Key Words: chronic bronchitis • COPD • exacerbation • infection
This article has been cited by other articles:
|
|
 |
|
  V. Avadhanula, C. A. Rodriguez, G. C. Ulett, L. O. Bakaletz, and E. E. Adderson Nontypeable Haemophilus influenzae Adheres to Intercellular Adhesion Molecule 1 (ICAM-1) on Respiratory Epithelial Cells and Upregulates ICAM-1 Expression Infect. Immun., February 1, 2006; 74(2): 830 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Braman Chronic Cough Due to Chronic Bronchitis: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 104S - 115S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rosell, E. Monso, N. Soler, F. Torres, J. Angrill, G. Riise, R. Zalacain, J. Morera, and A. Torres Microbiologic Determinants of Exacerbation in Chronic Obstructive Pulmonary Disease Arch Intern Med, April 25, 2005; 165(8): 891 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.N. de Melo, P. Ernst, and S. Suissa Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Eur. Respir. J., May 1, 2004; 23(5): 692 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. C. Gencay, M. Tamm, A. Glanville, A. P. Perruchoud, and M. Roth Chlamydia pneumoniae Activates Epithelial Cell Proliferation via NF-{kappa}B and the Glucocorticoid Receptor Infect. Immun., October 1, 2003; 71(10): 5814 - 5822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Irwin and J. M. Madison Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., June 26, 2003; 348(26): 2679 - 2681. [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. King, P. E. Hutchinson, P. D. Johnson, P. W. Holmes, N. J. Freezer, and S. R. Holdsworth Adaptive Immunity to Nontypeable Haemophilus influenzae Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 587 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sethi, N. Evans, B. J.B. Grant, and T. F. Murphy New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., August 15, 2002; 347(7): 465 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Birnbaum, M. Morley, P. E. Greenberg, and G. L. Colice Economic Burden of Respiratory Infections in an Employed Population* Chest, August 1, 2002; 122(2): 603 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sethi, T. F. Murphy, K. L. Nichol, T. K. Marras, L. C. Marras, and P. J. Barnes Chronic Obstructive Pulmonary Disease N. Engl. J. Med., December 28, 2000; 343(26): 1969 - 1971. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
